Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China

Shu Y, Zhang Q, He X, Chen L

Cancer Management and Research 2021, 13:8297-8306

Published Date: 3 November 2021